Skip to main content


Weitere Artikel dieser Ausgabe durch Wischen aufrufen

01.06.2015 | main topic | Ausgabe 11-12/2015

Wiener Medizinische Wochenschrift 11-12/2015

Drug safety aspects of herbal medicinal products

Wiener Medizinische Wochenschrift > Ausgabe 11-12/2015
Dr. T. Wegener, B. Deitelhoff, A. Silber-Mankowsky


There are numerous statements in the literature suggesting that the safety of herbal products or herbal medicinal products is inadequately considered. Despite the presence of risk, the potential is commonly underestimated as herbals are considered to be natural substances. It is necessary to consider the different categories of herbal products in the market. On one hand there are authorised herbal medicinal products (HMPs) which have adhered to the requirements to present data on quality, efficacy and safety. On the other hand there are products falling outside the use of marketing authorisations as for remedies. In the European Union (EU), HMPs are subject to an ambitious and comprehensive risk management system as for chemically defined drugs, which react effectively to risk concerns with scientific methods, as has been shown in the past. The established methods of pharmacovigilance and risk management favour the authorisation of herbal preparations for medicinal purposes as proprietary medicinal drugs.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

Abo für kostenpflichtige Inhalte

Über diesen Artikel

Weitere Artikel der Ausgabe 11-12/2015

Wiener Medizinische Wochenschrift 11-12/2015 Zur Ausgabe